result question manag
summari result
headlin core ep ahead consensu expect sole
due tax focus oper result broadli in-lin consensu expect
organ sale growth core ebit margin declin consensu flat
qualiti howev open challeng price neg group whole
first time sinc segment bar one price beauti flat addit gross
margin declin cf
highlight guid core tax rate beyond cf previou
expect
revis ep varianc primarili
relat incorpor revis tax guidanc updat fx translat
activist activist easi solut estim ebit gener
rate target price
maintain under-perform rate target price move
question manag
given heat natur recent proxi contest nelson peltz board
exan bnpp estim thomson reuter consensu list currenc dividend reinvest
date time london time invest recommend finalis may differ date time broad dissemin
websit appendix analyst certif import disclosur non-u research analyst disclosur
januari
result question
summari result
headlin core ep ahead consensu expect
sole due tax focus oper result broadli in-lin
consensu expect organ sale growth core ebit margin
declin consensu flat qualiti howev open challeng price
neg group whole first time sinc
segment bar one price beauti flat addit gross margin declin
cf
examin sale trend segment main surpris rel expect
beauti organ sale growth reflect mix volum
growth explain develop comment double-digit growth
skin person driven olay innov continu strong growth sk-
ii low-singl digit growth hair
figur outlin main element releas rel
consensu expect
figur summari result rel expect
varianc
figur outlin main element gs revis previou
figur summari guidanc
scope/fx impact sale
highlight main newsworthi item may easili glean
quick read releas
us tax transit impact new us tax regim result one-off
charg taken quarter paid year
larg off-set reduct defer tax liabil
on-going impact new us tax regim around earn
benefit quarter/ fiscal year around benefit
around benefit beyond relat cash benefit
on-going guid core tax
rate rate beyond
return increas share buy-back guidanc
around dividend payment expect return
sharehold fiscal year
one-off organ sale growth impact quarter around
gillett us price reduct anniversari april us
inventori reduct algeria ban finish product import
e-commerc last year gener sale e-commerc
goal reach year gs e-commerc grew quarter
categori grow market share
media alreadi reduc number agenc use nearli
save cost improv cash flow
better payment term target
save facilit reduct number
agenc intend autom media plan buy distribut
bring hous
us inventori reduct us inventori reduct larg part driven
one larg custom sell-out brand custom decemb
sell-in phenomenon unlik continu next quarter given
retail year-end tend januari
price commod cost increas guid
headwind yet increas point price taken
held shelf addit slower growth market environ also tend
competit price activ think long-term believ
structur shift industri price dynam
china achiev organ growth china quarter cf
includ pull forward shipment believ sk-
ii growth sustain attract level balanc beauti
busi perform well olay gs issu china primarili mid-
tier tape diaper segment deprioritis continu drag
time
market market growth around averag quarter lot
growth occur non-track channel emerg market growth around
quarter mark modest acceler market growth improv
decemb develop emerg market
margin declin core gross margin reflect product
save off-set commod cost mix
price primarili gillett reinvest product packag
innov sg declin sale reflect reduc
overhead agenc fee advertis product cost approxim top-
figur outlin revis previou ep estim
figur summari ep revis
varianc previou estim primarili relat impact incorpor
reduc tax guidanc updat fx translat
activist activist easi solut estim ebit
gener develop market
rate target price
maintain under-perform rate previous argu see unmov
 valu price-to-earnings continu employ
valuat methodolog light ep revis revis target
price
given heat natur recent proxi contest nelson peltz
question manag
board function well
board assess action point put forward trian initi white
given estim ebit gener us
pleas explain anticip bigger on-going benefit reduct
us tax rate
exit pgt jv novemb anniversari
thought regard continu jv
pgt asid would interest expand presenc consum
assess price realis sit rel market
intent take price increas order tri recov
commod headwind flag
mention made chang compens
programm includ rel sale growth total sharehold return
comment strong growth person health consequ
earli intens us cold flu season abl quantifi extent
busi benefit
pleas elabor quantifi algerian issu long
anticip continu persist
pleas remind us account sale made
read anyth recent small acquisit nativ deodor
one-off start becom activ acquisit front
given continu grow market confid
effici make intend continu make advertis
detriment impact health busi
pleas remind us rel import beauti brand
explain growth strong quarter
see evid suggest price action innov
us groom desir effect
pleas see overleaf revis segment sale profit loss account
fabric
babi feminin famili
profit taxat non-gaap
profit tax
tax pbt
tax pbt non-gaap
profit continu oper non-gaap
profit continu oper
profit discontinu oper
net profit attribut procter gambl
dividend payment prefer share
basic number share averag
fulli dilut number share averag
pay-out ratio basic non-gaap
dividend cover basic non-gaap
chg ebit non-gaap
depreci amortis
chg ebitda non-gaap
invest case valuat risk
activist activist easi solut estim ebit
gener develop market
valu price-to-earnings price-to-earnings
risk rate target price
risk would highlight includ possibl activist nelson peltz drive
posit chang anticip
cross mikheil omanadz jeff stent heidi vesterinen author contributor report herebi certifi view express report
accur reflect person view compani compani secur discuss report part compens
directli indirectli relat specif recommend view express research report
research analyst name involv prepar research report research analyst exan limit exan sa associ person
exan inc thu regist qualifi research analyst financi industri regulatori author finra new york stock
exchang nyse non-u analyst subject nasd rule nyse rule restrict commun subject compani
public appear trade secur held research analyst account
exan sa regul autorit de march financi amf franc exan limit authoris regul financi conduct author
unit kingdom exan inc regul finra secur exchang commiss unit state
research analyst respons prepar report receiv compens base upon variou factor includ overal firm revenu may
research analyst respons prepar report member household may relationship compani cover
research report describ number disclosur tabl immedi indic disclosur appli research
analyst respons prepar research report
research analyst respons prepar report member his/her household has/hav financi interest secur subject
company/i indic previou tabl
research analyst respons prepar report member his/her household serv offic director advisori board member
subject company/i indic previou tabl
research analyst respons prepar report receiv compens subject company/i indic previou tabl
exan sa exan limit exan inc collect exan may relationship compani cover research report describ
number disclosur tabl immedi indic disclosur appli exan relationship subject company/i
